Porcilis Pesti

RSS
Withdrawn

This medicine's authorisation has been withdrawn

adjuvanted vaccine against classical swine fever
MedicineVeterinaryWithdrawn
  • Application under evaluation
  • CVMP opinion
  • European Commission decision

Overview

The marketing authorisation for Porcilis Pesti has been withdrawn at the request of the marketing authorisation holder

български (BG) (389.2 KB - PDF)

View

español (ES) (186.61 KB - PDF)

View

čeština (CS) (318.5 KB - PDF)

View

dansk (DA) (190.05 KB - PDF)

View

Deutsch (DE) (357.3 KB - PDF)

View

eesti keel (ET) (186.1 KB - PDF)

View

ελληνικά (EL) (390.9 KB - PDF)

View

français (FR) (186.87 KB - PDF)

View

italiano (IT) (186.4 KB - PDF)

View

latviešu valoda (LV) (489.86 KB - PDF)

View

lietuvių kalba (LT) (299.13 KB - PDF)

View

magyar (HU) (476.92 KB - PDF)

View

Nederlands (NL) (186.4 KB - PDF)

View

polski (PL) (512.21 KB - PDF)

View

português (PT) (186.65 KB - PDF)

View

română (RO) (294.11 KB - PDF)

View

slovenčina (SK) (313.22 KB - PDF)

View

slovenščina (SL) (305.31 KB - PDF)

View

Suomi (FI) (186.2 KB - PDF)

View

svenska (SV) (200.67 KB - PDF)

View

Product information

български (BG) (857.85 KB - PDF)

View

español (ES) (220.29 KB - PDF)

View

čeština (CS) (416.9 KB - PDF)

View

dansk (DA) (226.72 KB - PDF)

View

Deutsch (DE) (430.62 KB - PDF)

View

eesti keel (ET) (269.28 KB - PDF)

View

ελληνικά (EL) (854.2 KB - PDF)

View

français (FR) (249.26 KB - PDF)

View

íslenska (IS) (223.38 KB - PDF)

View

italiano (IT) (226.44 KB - PDF)

View

latviešu valoda (LV) (692.49 KB - PDF)

View

lietuvių kalba (LT) (322.35 KB - PDF)

View

magyar (HU) (651.75 KB - PDF)

View

Malti (MT) (473.32 KB - PDF)

View

Nederlands (NL) (223.73 KB - PDF)

View

norsk (NO) (282.92 KB - PDF)

View

polski (PL) (531.76 KB - PDF)

View

português (PT) (222.35 KB - PDF)

View

română (RO) (323.19 KB - PDF)

View

slovenčina (SK) (437.6 KB - PDF)

View

slovenščina (SL) (427.77 KB - PDF)

View

Suomi (FI) (224.06 KB - PDF)

View

svenska (SV) (286.33 KB - PDF)

View
Latest procedure affecting product information: R/0011
16/09/2011

български (BG) (257.17 KB - PDF)

View

español (ES) (190.85 KB - PDF)

View

čeština (CS) (218.43 KB - PDF)

View

dansk (DA) (191.13 KB - PDF)

View

Deutsch (DE) (342.19 KB - PDF)

View

eesti keel (ET) (189.44 KB - PDF)

View

ελληνικά (EL) (235.88 KB - PDF)

View

français (FR) (190.16 KB - PDF)

View

íslenska (IS) (189.98 KB - PDF)

View

italiano (IT) (174.2 KB - PDF)

View

latviešu valoda (LV) (388.87 KB - PDF)

View

lietuvių kalba (LT) (220.48 KB - PDF)

View

magyar (HU) (366.11 KB - PDF)

View

Malti (MT) (251.16 KB - PDF)

View

Nederlands (NL) (189.72 KB - PDF)

View

norsk (NO) (174.66 KB - PDF)

View

polski (PL) (237.03 KB - PDF)

View

português (PT) (173.99 KB - PDF)

View

română (RO) (219.79 KB - PDF)

View

slovenčina (SK) (249.67 KB - PDF)

View

slovenščina (SL) (239.92 KB - PDF)

View

Suomi (FI) (190.65 KB - PDF)

View

svenska (SV) (191.41 KB - PDF)

View

Product details

Name of medicine
Porcilis Pesti
Active substance
Classical Swine Fever Virus (CSFV) -E2 subunit antigen
International non-proprietary name (INN) or common name
adjuvanted vaccine against classical swine fever
Species
Pigs
Anatomical therapeutic chemical veterinary (ATCvet) code
QI09AD04

Pharmacotherapeutic group

Immunologicals for suidae

Therapeutic indication

Active immunisation of pigs from the age of 5 weeks onwards to prevent mortality and to reduce clinical signs of Classical Swine Fever, as well as to reduce infection with and excretion of CSF field virus.
The onset of protection is 2 weeks.
The duration of protection is 6 months.

Authorisation details

EMA product number
EMEA/V/C/000046
Marketing authorisation holder
Intervet International BV

Wim de Körverstraat 35
5831 AN Boxmeer
The Netherlands

Marketing authorisation issued
09/06/2000
Revision
12

Assessment history

This page was last updated on

Share this page